Cortney Caudill - 01 Nov 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF OPERATING OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
01 Nov 2025
Net transactions value
-$277,905
Form type
4
Filing time
19 Dec 2025, 17:39:43 UTC
Previous filing
06 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Caudill Cortney SVP, CHIEF OPERATING OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 19 Dec 2025 0002090209

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +9,326 +122% $0.000000 17,000 01 Nov 2025 Direct
transaction HALO Common Stock Sale $277,905 -4,263 -25% $65.19 12,737 01 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -9,326 -33% $0.000000 18,651 01 Nov 2025 Common Stock 9,326 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 4,263 shares represents the shares that were withheld and sold by the issuer as payment for tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.